The Dynamics of the Human Immunodeficiency Virus Epidemics in the South of Brazil: Increasing Role of Injection Drug Users

Clinical Infectious Diseases

Volumn 37, Issue 12 SUPPL. 5, 2003, Pages

  Caiaffa, Waleska Teixeira ^a,b,d   Proietti, Fernando Augusto ^a,b   Carneiro Proietti, Anna Bárbara ^d   Mingoti, Sueli Aparecida ^c   Doneda, Denise ^e   Gandolfi, Denise ^e   Reis, Ângela Cristina Maia ^a,b  

^a Dept Preventative and Social Med ^*  (Brazil)

^b Research Group in Epidemiology and Health Service Evaluation   (Brazil)

^c Hemominas Foundation   (Brazil)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e MINISTÉRIO DA SAÚDE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAZIL; CONDOM; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; EPIDEMIC; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; INJECTION DRUG USER; INTRAVENOUS DRUG ABUSE; MONITORING; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PRISON; REVIEW; SCREENING; SEROPREVALENCE; SEXUAL BEHAVIOR; UNEMPLOYMENT;

ADULT; BRAZIL; DISEASE OUTBREAKS; FEMALE; HIV; HIV INFECTIONS; HUMANS; MALE; NEEDLE SHARING; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0348109303     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/377555     Document Type: Review

References (13)

1. Garfein RS, Vlahov D, Galai N, Doherty MC, Nelson KE. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency virus, and human T-lymphotropic viruses. Am J Public Health 1996; 86:655-61.
2. Crofts N. Going where the epidemic is. Epidemiology and control of hepatitis C among injecting drug users. Aust Fam Physician 2001; 30:420-5.
3. Oliveira MLA, Bastos FI, Telles PR, et al. Prevalence and risk factors for HBV, HCV and HIV infections among injecting drug users from Rio de Janeiro, Brazil. Braz J Med Biol Res 1999; 32:1107-14.
4. Diaz T, Des Jarlais DC, Vlahov D, et al. Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York City. Am J Public Health 2001; 91:23-30.
5. Thomas DL, Astemborski J, Rai RM, et al. Natural history of hepatitis C virus infection. JAMA 2000; 284:450-6.
6. Caiaffa WT, Bastos FI. Usuários de drogas injetáveis e infecção pelo vírus da imunodeficiência humana: epidemiologia e perspectivas de intervenção. Rev Bras Epidemiol 1998; 1:190-202.
7. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Soc Sci Med 2000; 51:1771-82.
8. a semana epidemiológica, January-March 2001. Brasilia, Brazil: Ministry of Health, 2001.
9. Teixeira P, Vitoria M, Barreira D, Dhalia C, Castilho E. AIDS epidemics in Brazil: present situation, national response and future trends. Actualizaciones em AIDS 2001;9:1-9.
10. Caiaffa WT. Projeto AjUDE-Brasil. Avaliação epidemiológica dos usuários de drogas injetáveis dos projetos de redução de danos apoiados pela CNDST e AIDS. Série Avaliação no. 6. Brasília, Brazil: Ministério da Saúde, 2001. Available at: http://www.aids.gov.br. Accessed 19 May 2003.
11. Watters JK, Biernacki P. Targeted sampling: options for the study of hidden population. Soc Probl 1989; 331:1422-30.
12. Monterroso ER, Hamburger ME, Vlahov D, et al. Prevention of HIV infection in street-recruited injection drug users. J Acquir Immune Defic Syndr 2000; 25:63-70.
13. United Nations Joint Programme on HIV/AIDS. Trends in HIV incidence and prevalence: natural course of the epidemic or results of behavioural change? Geneva: World Health Organization, 1999.